Komori
Other Disclosures4886ASKA Pharmaceutical Holdings Co.,Ltd.Pharmaceuticals

Notice of the Continued Selection of Constituent Stocks for the ESG Investment Indices “FTSE JPX Blossom Japan Index” and “FTSE JPX Blossom Japan Sector Relative Index”

The Company has again been selected as a constituent of the ESG investment indices “FTSE JPX Blossom Japan Index” and “FTSE JPX Blossom Japan Sector Relative Index.”

Worth reading
42Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

FTSE JPX Blossom Japan IndexFTSE JPX Blossom Japan Sector Relative Index
Applicable field (uses covered by this announcement)

ESG investment, sustainable investment, environmental, social and governance

What the company reported numerically
Usage history

The Company has been selected for the FTSE JPX Blossom Japan Index for 4 consecutive years since 2023. It has been selected for the FTSE JPX Blossom Japan Sector Relative Index for 5 consecutive years since 2022.

Relationship between the counterparty and the company
ASKA Pharmaceutical Holdings Co.,Ltd.4886
Relationship with the Company

The Company has been continuously selected as a constituent of both indices.

CounterpartyFTSE Russell; Government Pension Investment Fund (GPIF)

FTSE Russell is a global index provider. GPIF is an independent administrative agency that manages and invests public pension reserves.

Location (as indicated in this announcement)

Minato-ku, Tokyo

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Source (materials cited by the company)

FTSE Russell

Announced details
ItemDetails
Names of Products / Services CoveredFTSE JPX Blossom Japan Index, FTSE JPX Blossom Japan Sector Relative Index
CounterpartyFTSE Russell; Government Pension Investment Fund (GPIF)
Counterparty overviewFTSE Russell is a global index provider. GPIF is an independent administrative agency that manages and invests public pension reserves.
Relationship with the CompanyThe Company has been continuously selected as a constituent of both indices.
Applicable areaESG investment, sustainable investment, environmental, social and governance
LocationMinato-ku, Tokyo
Usage historyThe Company has been selected for the FTSE JPX Blossom Japan Index for 4 consecutive years since 2023. It has been selected for the FTSE JPX Blossom Japan Sector Relative Index for 5 consecutive years since 2022.
SourceFTSE Russell
Items this document does not state (10)
Contract ValueOffering priceContract DateLaunch dateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Company’s environmental, social and governance (ESG) initiatives meet the evaluation criteria. The Company states that it will continue to pursue ESG initiatives proactively, with the aim of achieving sustainable growth and enhancing corporate value over the medium to long term.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of the Continued Selection of Constituent Stocks for the ESG Investment Indices “FTSE JPX Blossom Japan Index” and “FTSE JPX Blossom Japan Sector Relative Index” | ASKA Pharmaceutical Holdings Co.,Ltd. (4886) timely disclosure | Komori